ASHLEY DENTON: Open Payments
NPI 1932666252 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,351 in 120 payments from 29 companies in 2025. Trend: 2023 $2,370 · 2024 $2,795 · 2025 $2,351
Food & beverage: $2,251Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $280 |
| Novartis Pharmaceuticals Corporation | 20 | $271 |
| Merck Sharp & Dohme LLC | 11 | $217 |
| Regeneron Healthcare Solutions, Inc. | 6 | $205 |
| Daiichi Sankyo Inc. | 8 | $181 |
| Incyte Corporation | 5 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| PFIZER INC. | 6 | $93 |
| Exelixis Inc. | 5 | $81 |
| Ipsen Biopharmaceuticals, Inc | 4 | $76 |
Products named: LIBTAYO, KEYTRUDA, ERLEADA, Fabhalta, CABOMETYX, BRUKINSA, Onivyde, DATROWAY.
Industry payments across AR — which companies pay providers there.
